Interventions modelled | Baseline | Simulation protocol | |
---|---|---|---|
Conservative | Optimistic | ||
Antiretroviral therapy coverage among eligible subjects (%) | |||
CD4 ≤ 350 cells/mm3 | 69 % | 80 % | 90 % |
CD4 ≤ 500 cells/mm3 or PMTCT option B+ | 51 % | 80 % | 90 % |
All-CD4 | 40 % | 80 % | 90 % |
Voluntary medical male circumcision among uninfected men | |||
15–24 years | 42 % | 75 % | 90 % |
25–34 years | 17 % | 30 % | 70 % |
35–59 years | 5 % | 10 % | 60 % |
All | 25 % | 50 % | 80 % |
Pre-exposure prophylaxis among uninfected women | |||
15–24 years | - | 60 % | 80 % |
25–34 years | - | 10 % | 30 % |
35–59 years | - | 10 % | 20 % |
All | - | 34 % | 51 % |